QTTB
Q32 BioFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
QTTB vs peer average
29/100
QTTB vs. peer average (F vs. D)
Grade spread
A 1 · B 1 · C 2 · D 2 · F 4
Graded peers loaded
Coverage
10 graded
91% of tracked
Peer overview
INMB is the first available peer comparator.
Clinical-stage biotech with similar small-cap volatility and dependence on future data; again a loose risk-profile peer rather than a direct alopecia/immunology comp.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
QTTB
Q32 Bio
INMB
INmune Bio
Grade
F
F
Momentum
8
16
Value
57
41
Sentiment
19
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs INMB
QTTB / INMB
Grade Position
Below peers
QTTB vs. peer average (F vs. D)
29/100
Momentum
8
INMBValue
57
QTTBSentiment
19
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs QTTB
INMB is the first peer returned for this comparison set.